Showing results (481-490 of 570) with videos related to

Sort By:
Pageof 57
Molecular Oncology|August 9, 2019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibitionKara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
AIDS (London, England)|August 11, 2022
Trans women have worse cardiovascular biomarker profiles than cisgender men independent of hormone use and HIV serostatusJordan E Lake, Ruibin Wang, Benjamin W Barrett, et al.
Analytica Chimica Acta|March 2, 2025
Evaluation of tissue-specific extraction protocols for comprehensive lipid profilingDana Hicks, Monique J Ryan, Amira Allahham, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2000
A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chainsB P England, P Balasubramanian, I Uings, et al.
The Journal of Biological Chemistry|November 29, 1996
AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1A L Akeson, C W Woods, L C Hsieh, et al.
Cancer Research|December 11, 2012
Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinomaCaitlyn W Barrett, Wei Ning, Xi Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 16, 2020
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinomaKara M Ruicci, Jalna Meens, Paul Plantinga, et al.
Stem Cells (Dayton, Ohio)|February 19, 2016
BVES Regulates Intestinal Stem Cell Programs and Intestinal Crypt Viability after RadiationVishruth K Reddy, Sarah P Short, Caitlyn W Barrett, et al.
The American Journal of Emergency Medicine|January 22, 2017
Missed myocardial infarctions in ED patients prospectively categorized as low risk by established risk scoresA J Singer, M P Than, S Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breastL J Solin, J Kurtz, A Fourquet, et al.
Pageof 57